EP Patent

EP2322190A1 — Compositions for bowel cleansing and use thereof

Assigned to Promefarm SRL · Expires 2011-05-18 · 15y expired

What this patent protects

The present invention relates to a dry composition for reconstitution in water comprising polyethylene glycol (PEG), optionally sodium sulphate, citric acid, sodium citrate, sodium chloride, potassium chloride, simethicone, effective for bowel cleansing, in particular of colon, p…

USPTO Abstract

The present invention relates to a dry composition for reconstitution in water comprising polyethylene glycol (PEG), optionally sodium sulphate, citric acid, sodium citrate, sodium chloride, potassium chloride, simethicone, effective for bowel cleansing, in particular of colon, prior to diagnostic, surgical or therapeutical procedures, in particular colonoscopy.

Drugs covered by this patent

Patent Metadata

Patent number
EP2322190A1
Jurisdiction
EP
Classification
—
Expires
2011-05-18
Drug substance claim
No
Drug product claim
No
Assignee
Promefarm SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.